Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Cardiovasc Pharmacol ; 78(6): 858-866, 2021 12 01.
Article in English | MEDLINE | ID: mdl-34596621

ABSTRACT

ABSTRACT: Paracetamol (PAR) is the most common over-the-counter drug recommended by physicians for treatment of pain and fever during gestation. This drug is not teratogenic, being considered safe for fetus; however, PAR crosses the blood-placental barrier. Considering that, the present study aimed to evaluate the vascular and metabolic safety of PAR exposure during intrauterine and neonatal development in adult male and female-exposed offspring. Wistar female rats were gavaged, with PAR (350 mg/kg/d), from gestational day 6-21 or from gestational day 6 until postnatal day 21. Control dams received water by gavage at the same periods. The male and female offspring were evaluated at adulthood (80 days of life). The thoracic aorta reactivity to acetylcholine, sodium nitroprusside, and phenylephrine was evaluated in male and female adult offspring. It was observed that aortic relaxation was similar between the PAR and control offspring. In addition, the contraction to phenylephrine was similar between the groups. Further, the insulin sensitivity, adipose tissue deposition and blood pressure were not different between PAR and control adult offspring. These results suggest that the protocol of PAR exposure used in the present study did not program vascular and metabolic alterations that would contribute to the development of cardiometabolic diseases in adult life, being safe for the exposed offspring.


Subject(s)
Acetaminophen/toxicity , Analgesics, Non-Narcotic/toxicity , Cardiovascular Diseases/chemically induced , Lactation , Metabolic Diseases/chemically induced , Prenatal Exposure Delayed Effects , Adiposity/drug effects , Animals , Aorta, Thoracic/drug effects , Aorta, Thoracic/physiopathology , Cardiovascular Diseases/physiopathology , Female , Gestational Age , Hemodynamics/drug effects , Insulin Resistance , Male , Metabolic Diseases/blood , Metabolic Diseases/physiopathology , Pregnancy , Rats, Wistar , Risk Assessment
SELECTION OF CITATIONS
SEARCH DETAIL
...